Cargando…

PB2125: LYMPHOMATOID PAPULOSIS-LIKE (LYP-LIKE) AFTER BRENTUXIMAB VEDOTIN-CHP (BV-CHP) TREATMENT FOR ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

Detalles Bibliográficos
Autores principales:	Lopez Pereira, P., Servitje, O., Climent, F., Domingo-Domenech, E., Oliveira, A., Muniesa, C., Sureda, A., González-Barca, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429098/ http://dx.doi.org/10.1097/01.HS9.0000851332.62295.97

Ejemplares similares

Brentuximab Vedotin Plus CHP in Frontline sALCL: Adjusted Estimates of Efficacy and Cost-Effectiveness Removing the Effects of Re-Treatment with Brentuximab Vedotin
por: Cranmer, Holly, et al.
Publicado: (2022)

A Rare Case of Grey Zone Lymphoma Successfully Treated with Brentuximab Vedotin and R-CHP Chemotherapy
por: Mallipudi, Rajiv M., et al.
Publicado: (2019)

Role of stem cell transplant in CD30(+) PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
por: Savage, Kerry J., et al.
Publicado: (2022)

P1130: FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 STUDY SGN35-032
por: Iyer, Swaminathan, et al.
Publicado: (2023)

Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD)
por: Hong, Jennifer, et al.
Publicado: (2021)

Antimicrobial activity of chicken and turkey heterophil peptides CHP1, CHP2, THP1, and THP3
por: Evans, Ellen W., et al.
Publicado: (1995)

Relationship among Chinese herb polysaccharide (CHP), gut microbiota, and chronic diarrhea and impact of CHP on chronic diarrhea
por: Xue, Hong, et al.
Publicado: (2023)

The Successful Use of Neo Adjuvant Brentuximab Vedotin in the Treatment of BIA-ALCL
por: Allchin, Rebecca L., et al.
Publicado: (2020)

Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma
por: Shemesh, Colby S., et al.
Publicado: (2020)

Cogeneration--combined heat and power (CHP) : thermodynamics and economics /
por: Horlock, J. H.
Publicado: (1997)

Type B lymphomatoid papulosis
por: Bouhamidi, Ahmed, et al.
Publicado: (2018)

The binding of Chp2’s chromodomain to methylated H3K9 is essential for Chp2’s role in heterochromatin assembly in fission yeast
por: Maksimov, Vladimir, et al.
Publicado: (2018)

A child with mastocytosis and lymphomatoid papulosis
por: Lange, Henriette Juel, et al.
Publicado: (2016)

Lymphomatoid papulosis responding to topical methotrexate
por: Smilga, Anne-Sophie, et al.
Publicado: (2021)

Brentuximab Vedotin
Publicado: (2012)

Lymphomatoid Papulosis Development in Acute Lymphoblastic Leukemia
por: Oura, Kazumi, et al.
Publicado: (2021)

The relevance of complete imaging investigations in lymphomatoid papulosis
por: Chersi, Filippo, et al.
Publicado: (2022)

Structure and mechanism of the human NHE1-CHP1 complex
por: Dong, Yanli, et al.
Publicado: (2021)

CHP2 gene expression and quantitation in Egyptian patients with acute leukemia
por: Hammam, Amira Ahmed, et al.
Publicado: (2014)

PLS3 Overexpression Delays Ataxia in Chp1 Mutant Mice
por: Janzen, Eva, et al.
Publicado: (2019)

Structural basis of autoinhibition of the human NHE3-CHP1 complex
por: Dong, Yanli, et al.
Publicado: (2022)

Lymphomatoid papulosis in a young adult of African descent
por: Angra, Kunal, et al.
Publicado: (2015)

Lymphomatoid papulosis during upadacitinib treatment for rheumatoid arthritis
por: Iinuma, Shin, et al.
Publicado: (2022)

Communications and High-Precision Positioning (CHP2): Hardware Architecture, Implementation, and Validation
por: Yu, Hanguang, et al.
Publicado: (2023)

Angiodestructive lymphomatoid papulosis lasting more than 45 years
por: Lee, Gun Ho, et al.
Publicado: (2019)

Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis
por: Melchers, R.C., et al.
Publicado: (2019)

Lymphomatoid papulosis successfully managed with excimer laser maintenance therapy
por: Reddy, Vidhatha, et al.
Publicado: (2020)

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK(+) ALCL: results of COG trial ANHL12P1
por: Lowe, Eric J., et al.
Publicado: (2021)

Brentuximab vedotin induced uveitis
por: Therssen, Stijn, et al.
Publicado: (2022)

Primary Cutaneous CD30+/ALK- ALCL with Transition into sALCL: Favourable Response after Systemic Administration with Brentuximab Vedotin! Unique Presentation in a Bulgarian Patient!
por: Popova, Tanya Naskova, et al.
Publicado: (2018)

Production optimization of cyanophycinase ChpE(al )from Pseudomonas alcaligenes DIP1
por: Sallam, Ahmed, et al.
Publicado: (2011)

CHP Engine Anomaly Detection Based on Parallel CNN-LSTM with Residual Blocks and Attention
por: Chung, Won Hee, et al.
Publicado: (2023)

PRES-like leukoencephalopathy presenting with status epilepticus associated with Brentuximab Vedotin treatment
por: Orsini, Alessandro, et al.
Publicado: (2021)

Regional Lymphomatoid Papulosis Arising after Total Mastectomy for Breast Cancer
por: Bae, Jai H., et al.
Publicado: (2022)

Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013)

Brentuximab vedotin: axonal microtubule's Apollyon
por: Mariotto, S, et al.
Publicado: (2015)

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma
por: Castellino, Sharon M., et al.
Publicado: (2022)

The Chp1-Tas3 core is a multifunctional platform critical for gene silencing by RITS
por: Schalch, Thomas, et al.
Publicado: (2011)

Structural insights into ChpT, an essential dimeric histidine phosphotransferase regulating the cell cycle in Caulobacter crescentus
por: Fioravanti, Antonella, et al.
Publicado: (2012)

Small and micro combined heat and power (CHP) systems: advanced design, performance, materials and applications
por: Beith, R
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4tqu4ehdnc2cogpubdk18l6die